KESPION Co., Ltd. (KOSDAQ:079190)
South Korea
· Delayed Price · Currency is KRW 476.00
+2.00 (0.42%)
At close: Aug 13, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Telecommunications | 35.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Telecommunications Growth | -47.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -3.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | -46.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Skin Beauty Medical Device | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Skin Beauty Medical Device Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -3.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | -46.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Consolidated Adjustment | -3.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | -46.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vietnam | 28.94B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vietnam Growth | -49.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 6.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -40.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -3.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | -46.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|